DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie

References

Sandborn WJ, Korzenik J, Lashner B. et al.
Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitis.

Gastroenterology 2010;
138: 1286-1296, 1296 e1–3

Download Bibliographical Data

Access:
Access: